Rare diseases
Investigational molecules
Locations
Back to Germany987 clinical trials in Heilbronn, Germany across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)Study on Birtamimab and Bortezomib for Patients with Advanced Light Chain Amyloidosis
GermanyStudy of RO7790121 Compared to Placebo for Treatment of Adults with Moderate to Severe Ulcerative Colitis
GermanyStudy of Tiragolumab and Atezolizumab for Patients with Advanced Non-Small Cell Lung Cancer
GermanyThe busiest research cities in the country
What the registry says about research in the country
Innovative trials focusing on Acute Myeloid Leukemia (AML) and Chronic Lymphocytic Leukemia, testing novel drug combinations to improve patient outcomes. Research includes evaluating treatments for both adult and pediatric patients with various forms of leukemia.
Studies aim to enhance survival rates and develop more effective treatment strategies for blood cancer patients.
Comprehensive studies addressing different types of breast cancer, particularly focusing on triple-negative breast cancer and HER2-positive disease. Research includes both early-stage and metastatic disease treatments.
Trials evaluate novel drug combinations and targeted therapies to improve patient outcomes.
Research focusing on various digestive system cancers, including gastric cancer, colorectal cancer, and pancreatic cancer. Studies evaluate both early-stage and advanced disease treatments.
Investigations aim to improve surgical outcomes and treatment effectiveness for GI cancers.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
